TITLE

Disease progression continues, in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation

AUTHOR(S)
Hilker, R.; Portman, A. T.; Voges, J.; Staal, M. J.; Burghaus, L.; Van Bar, T.; Koulousakis, A.; Maguire, R. P.; Pruim, J.; De Jong, B. M.; Herholz, K.; Slurm, V.; Heiss, W-D.; Beenders, K. L.
PUB. DATE
September 2005
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Sep2005, Vol. 76 Issue 9, p1217
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: Glutamate mediated excitotoxicity of the hyperactive subthalamic nucleus (STN) has been reported to contribute to nigral degeneration in Parkinson's disease (PD). Deep brain stimulation of the STN (STN DBS), in its role as a highly effective treatment of severe PD motor complications, has been thought to inhibit STN hyperactivity and therefore decrease progression of PD. Methods: In a prospective two centre study, disease progression was determined by means of serial 18F-fluorodopa (F-dopa) positron emission tomography (PET) in 30 patients with successful SIN DBS over the first 16 (SD 6) months after surgery. Results: Depending on the method of PET data analysis used in the two centres, annual progression rates relative to baseline were 9.5-12.4% in the caudate and 10.7-12.9% in the putamen. Conclusions: This functional imaging study is the first to demonstrate a continuous decline of dopaminergic function in patients with advanced PD under clinically effective bilateral STN stimulation. The rates of progression in patients with STN DBS were within the range of previously reported data from longitudinal imaging studies in PD. Therefore this study could not confirm the neuroprotective properties of DBS in the STN target.
ACCESSION #
18199122

 

Related Articles

  • Tiefe Hirnstimulation bei Morbus Parkinson: wann und für wen? Erasmi, R.; Deuschl, G.; Witt, K. // Der Nervenarzt;Feb2014, Vol. 85 Issue 2, p137 

    Deep brain stimulation (DBS) is an effective and evidence-based treatment option for Parkinson's disease. Studies have shown that DBS has good and long-term effects on motor function and quality of life for patients in an advanced stage of the disease and that it is more effective than medical...

  • Subthalamic nucleus deep brain stimulation does not alter long-term heart rate variability in Parkinson’s disease. Erola, Tuomo; Haapaniemi, Tarja; Heikkinen, Esa; Huikuri, Heikki; Myllyä, Vilho // Clinical Autonomic Research;Aug2006, Vol. 16 Issue 4, p286 

    The power spectra of the heart rate variability frequency bands, analyzed from 24-hour ECG recordings, did not change 12 months after bilateral subthalamic nucleus operation in 14 patients with Parkinson’s disease.

  • Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease: A controlled comparative study. Gironell, Alexandre; Kulisevsky, Jaime; Rami, Lorena; Fortuny, Núria; García-Sánchez, C.; Pascual-Sedano, Berta // Journal of Neurology;Aug2003, Vol. 250 Issue 8, p917 

    Unilateral pallidotomy and bilateral subthalamic deep brain stimulation (STN-DBS) for Parkinson’s disease (PD) have demonstrated a positive effect on motor functions. However, further studies are needed of the unintended cognitive effects accompanying these new surgical procedures. We...

  • Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation. Lubik, S.; Fogel, W.; Tronnier, V.; Krause, M.; König, J.; Jost, W. H. // Journal of Neural Transmission;Feb2006, Vol. 113 Issue 2, p163 

    The aim of our study was to observe the effects on gait parameters induced by STN stimulation and levodopa medication in patients with advanced Parkinson’s disease in order to determine different or additive effects. Therefore we examined 12 patients with advanced Parkinson disease after...

  • The effect of deep brain stimulation on quality of life in movement disorders. Diamond, A.; Jankovic, J. // Journal of Neurology, Neurosurgery & Psychiatry;Sep2005, Vol. 76 Issue 9, p1188 

    Deep brain stimulation (DBS) is a viable treatment alternative for patients with Parkinson's disease (PD), essential tremor (ET), dystonia, and cerebellar outflow tremors. When poorly controlled, these disorders have detrimental effects on the patient's health related quality of life (HRQoL)....

  • Does chronic subthalamic nucleus stimulation in advanced Parkinson's disease cause invalidating cognitive and behavioural dysfunctions? Speelman, J. D.; Smeding, H. M. M.; Schmand, B. // Journal of Neurology, Neurosurgery & Psychiatry;Mar2007, Vol. 78 Issue 3, p221 

    The article offers a critical look if chronic subthalamic nucleus stimulation (STN) in advanced Parkinson's disease can cause invalidation of cognitive and behavioral dysfunctions. One clinical study revealed that chronic deep brain stimulation of STN accomplishes favorable long-term...

  • Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease. Klostermann, F.; Ehlen, F.; Vesper, J.; Nubel, K.; Gross, M.; Marzinzik, F.; Curio, G.; Sappok, T. // Journal of Neurology, Neurosurgery & Psychiatry;May2008, Vol. 79 Issue 5, p522 

    Background: Motor deficits in Parkinson's disease (PD) are reduced by deep brain stimulation (DBS) of the subthalamic nucleus (STN), but the impact of this therapy on dysarthrophonic problems in PD remains controversial. We therefore aimed to disentangle the effects of STN DBS on the speech...

  • Apathy and verbal fluency in STN-stimulated PD patients. Castelli, L.; Lanotte, M.; Zibetti, M.; Caglio, M.; Rizzi, L.; Ducati, A.; Bergamasco, B.; Lopiano, L. // Journal of Neurology;Sep2007, Vol. 254 Issue 9, p1238 

    To evaluate apathy and its relation to verbal fluency tasks in a consecutive series of 19 patients with Parkinson's disease (PD) submitted to deep brain stimulation of the subthalamic nucleus (DBS of STN). 19 consecutive PD patients submitted to bilateral DBS of STN were studied for apathy...

  • Battery life following pallidal deep brain stimulation (DBS) in children and young people with severe primary and secondary dystonia. Lumsden, Daniel; Kaminska, Margaret; Tustin, Kylie; Gimeno, Hortensia; Baker, Lesley; Ashkan, Keyoumars; Selway, Richard; Lin, Jean-Pierre // Child's Nervous System;Jul2012, Vol. 28 Issue 7, p1091 

    Background: The finite life of non-rechargeable batteries powering implantable pulse generators (IPG) necessitates their periodic replacement. Children receiving deep brain stimulation (DBS) may require frequent battery changes over their treatment lifetime. Objectives: We aimed to determine the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics